Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rank in Stocks #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Share Price
$0.0009
Last synced: 2025-05-27
Market Cap
$1.15K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Arch Therapeutics, Inc. (ARTH)

Category

Dividend yield history for Arch Therapeutics, Inc. (ARTH)
Arch Therapeutics, Inc. (stock symbol: ARTH) dividend yield (TTM) as of 2022-09-30: 0.00%
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Arch Therapeutics, Inc. (ARTH) from 2011 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
Dividend yields (TTM) for similar companies or competitors